---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-053914"
form_type: "8-K"
ticker: "BNBX"
cik: "0000744452"
company_name: "BNB PLUS CORP."
filed_at: "2025-05-29T23:59:59+00:00"
generated_at: "2026-05-20T07:09:26.691371+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Applied DNA announces 1-for-15 reverse stock split effective June 2, 2025

## Summary
- Reverse stock split ratio set at 1-for-15; effective 12:01 a.m. ET on June 2, 2025.
- Outstanding shares reduce from ~7.8M to ~519K; fractional shares rounded up to nearest whole.
- Stock continues trading on Nasdaq under ticker APDN with new CUSIP 03815U607.
- Split intended to bring company into compliance with Nasdaq $1.00 minimum bid price requirement.
- Board approved ratio on May 27, 2025; stockholder authorization obtained at May 22 annual meeting.

## SEC filing metadata
- accession: 0001104659-25-053914
- form_type: 8-K
- ticker: BNBX
- cik: 0000744452
- company_name: BNB PLUS CORP.
- filed_at: 2025-05-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744452/000110465925053914/0001104659-25-053914-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744452/000110465925053914/tm2516427d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-053914
- JSON: https://secwatch.observer/filing/0001104659-25-053914.json
- Plain text: https://secwatch.observer/filing/0001104659-25-053914.txt

## Key facts
- Governance Changes
  BNB PLUS CORP.: Certificate of Incorporation amended to effect a 1-for-15 reverse stock split (effective 2025-06-02).
  - Change: charter amendment
  - Effective: 2025-06-02
  source text: At the 2025 Annual Meeting of Stockholders (the “Annual Meeting”) held on May 22, 2025, the stockholders of Applied DNA Sciences, Inc. (the “Company”) authorized the board of directors of the Company (the “Board”), in its discretion, to amend the Company’s Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to effect a reverse split of the Company’s outstanding common stock, par value $0.001 (the “Common Stock”), at a ratio between one-for-five (1:5) and one-for-fifty (1:50), with such final ratio to be determined by the Board. The Board determined to set the reverse stock split ratio at one-for-fifteen (1:15) (the “Reverse Stock Split”) and approved the final form of the Certificate of Amendment to the Certificate of Incorporation to effectuate the Reverse Stock Split (the “Certificate of Amendment”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/744452/000110465925053914/0001104659-25-053914-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.